Search research articles
Contact Us
Filters
Showing results (171-180 of 326) with videos related to
Page
of 33
Sort By:
Cancers
|
March 29, 2023
Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Gian Paolo Caviglia, Amina Abdulle, et al.
The New England Journal of Medicine
|
April 30, 2025
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
Arun J Sanyal, Philip N Newsome, Iris Kliers, et al.
Minerva Medica
|
May 14, 2019
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study
Chiara Rosso, Gian Paolo Caviglia, Michela Ciruolo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 11, 2012
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C
Salvatore Petta, Chiara Rosso, Reynold Leung, et al.
Hepatology (Baltimore, Md.)
|
June 21, 2011
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study
Neeraj Bhala, Paul Angulo, David van der Poorten, et al.
European Journal of Internal Medicine
|
January 21, 2022
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis
Christian Labenz, Gerrit Toenges, Ming-Hua Zheng, et al.
Hepatology (Baltimore, Md.)
|
December 22, 2017
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein
Elisabetta Morello, Salvatore Sutti, Beatrice Foglia, et al.
Diagnostic Microbiology and Infectious Disease
|
February 4, 2020
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection
Gian Paolo Caviglia, Antonella Olivero, Alessia Ciancio, et al.
Alimentary Pharmacology & Therapeutics
|
April 10, 2025
Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease
Gian Paolo Caviglia, Elisabetta Casalone, Chiara Rosso, et al.
Cancers
|
June 2, 2021
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Gian Paolo Caviglia, Angelo Armandi, Chiara Rosso, et al.
Page
of 33
Search research articles
Search
Showing results (171-180 of 326) with videos related to
Sort By:
Page
of 33
Cancers
|
March 29, 2023
Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease
Angelo Armandi, Gian Paolo Caviglia, Amina Abdulle, et al.
The New England Journal of Medicine
|
April 30, 2025
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis
Arun J Sanyal, Philip N Newsome, Iris Kliers, et al.
Minerva Medica
|
May 14, 2019
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study
Chiara Rosso, Gian Paolo Caviglia, Michela Ciruolo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 11, 2012
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C
Salvatore Petta, Chiara Rosso, Reynold Leung, et al.
Hepatology (Baltimore, Md.)
|
June 21, 2011
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study
Neeraj Bhala, Paul Angulo, David van der Poorten, et al.
European Journal of Internal Medicine
|
January 21, 2022
Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis
Christian Labenz, Gerrit Toenges, Ming-Hua Zheng, et al.
Hepatology (Baltimore, Md.)
|
December 22, 2017
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein
Elisabetta Morello, Salvatore Sutti, Beatrice Foglia, et al.
Diagnostic Microbiology and Infectious Disease
|
February 4, 2020
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection
Gian Paolo Caviglia, Antonella Olivero, Alessia Ciancio, et al.
Alimentary Pharmacology & Therapeutics
|
April 10, 2025
Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease
Gian Paolo Caviglia, Elisabetta Casalone, Chiara Rosso, et al.
Cancers
|
June 2, 2021
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Gian Paolo Caviglia, Angelo Armandi, Chiara Rosso, et al.
Page
of 33